Oryzon Genomics SA
OTC:ORYZF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oryzon Genomics SA
OTC:ORYZF
|
ES |
|
Aizawa Securities Group Co Ltd
TSE:8708
|
JP |
|
H
|
HAL Trust
OTC:HALFF
|
NL |
|
R
|
Rig Tenders Indonesia Tbk PT
IDX:RIGS
|
ID |
|
Black Cat Syndicate Ltd
OTC:BLCAF
|
AU |
|
Societatea de Producere a Energiei Electrice in Hidrocentrale Hidroelectrica SA
F:E28
|
RO |
|
Ostrom Climate Solutions Inc
XTSX:COO
|
CA |
|
B
|
Bitcoin Group SE
DUS:ADE
|
DE |
|
TransAct Technologies Inc
NASDAQ:TACT
|
US |
|
Rubrik Inc
F:X68
|
US |
|
Zedur Enerji Elektrik Uretim AS
IST:ZEDUR.E
|
TR |
|
M
|
Metro Mining Ltd
F:6ME
|
AU |
|
G
|
Golden Agri-Resources Ltd
XMUN:4G3A
|
SG |
|
S
|
Science To Consumers Inc
OTC:BEUT
|
US |
|
S
|
Sadhna Broadcast Ltd
BSE:540821
|
IN |
|
G
|
Glenveagh Properties PLC
XMUN:GVR
|
IE |
|
E
|
Evoke PLC
F:C8V
|
GI |
|
G
|
Grupo Televisa SAB
F:TLV
|
MX |
Intrinsic Value
Is ORYZF undervalued or overvalued?
See the intrinsic value estimate for 
Oryzon Genomics SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Oryzon Genomics Does
Oryzon Genomics is a drug development company focused on medicines that change how genes are switched on and off. Its main work is discovering and testing epigenetic drugs, especially compounds that block LSD1, an enzyme involved in cancer and some brain disorders. The company does not sell everyday consumer products; it builds drug candidates that may eventually be licensed or sold as prescription medicines if they win approval.
- Headquarters
- Spain ES
- Employees
- 46
- IPO date
- Dec 10, 2015
Earnings Waterfall
Oryzon Genomics SA
The intrinsic value for Oryzon Genomics SA (ORYZF) under the Base Case is hidden USD.
Compared with the current market price of 3.0975 USD, the stock appears hidden.
